Ardea Resources Limited (ASX:ARL) (OTCMKTS:ARRRF) is developing its flagship Goongarrie Nickel Cobalt Project as a "state-of-the-art" battery metals project, with innovative Research and Development a key pillar of the metallurgical programs. The quality of the GNCP research has been recognised with a $2.5 million refund from the Federal Government Australian Tax Office.
Ardea Resources Ltd (ASX:ARL) (OTCMKTS:ARRRF) provides the Company's latest Investor Presentation.
Mithril Resources Limited (ASX:MTH) advises that further to the results of the Extraordinary General Meeting held yesterday that its Board of Directors now comprises Mr David Hutton (Managing Director), Mr Adrien Wing (Non-Executive Director) and Mr Stephen Layton (Non-Executive Director).
Intermin Resources Limited (ASX:IRC) provides the Company's latest Investor Presentation.
Emerging lithium miner Sayona Mining Limited (ASX:SYA) (OTCMKTS:DMNXF) announced today the strengthening of its Québec management team, with the appointment of globally experienced mining project director and construction manager Guy Laliberté as the Company's Chief Executive Officer, Sayona Québec Inc.
Ardea Resources Ltd (ASX:ARL) (OTCMKTS:ARRRF) provides the Company's latest presentation.
Lithium Power International Limited (ASX:LPI) (OTCMKTS:LTHHF) is pleased to submit its quarterly Activity Report for the period ended 31 March 2019.
Banking & Finance
- YPB Group Ltd (ASX:YPB) Update on YPB Token
- Goldfields Money Ltd (ASX:GMY) Key Operating Metrics - November 2018
- YPB Group Ltd (ASX:YPB) Non-Executive Director Appointment
Oil Gas & Energy
- Central Petroleum Limited (ASX:CTP) Palm Valley 13 Well Commenced Flowing Sales Gas
- Central Petroleum Limited (ASX:CTP) Appointment of Chief Financial Officer
- Liquefied Natural Gas Ltd (ASX:LNG) Provides Update, Will Host Investor Conference Call
- MMJ Group Holdings Ltd (ASX:MMJ) To Present at Investor Conference
- VIDEO: Ellis Martin Report: Matinas BioPharma (NYSE:MTNB) Announces a Research Collaboration with ViiV Healthcare to Evaluate Formulation of Antiviral Drug Candidates
- Anatara Lifesciences Ltd (ASX:ANR) PAC Partners Equity Research Report